165 related articles for article (PubMed ID: 33083904)
1. Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis.
Kovacheva M; Zepp M; Berger S; Berger MR
J Cancer Res Clin Oncol; 2021 Feb; 147(2):361-371. PubMed ID: 33083904
[TBL] [Abstract][Full Text] [Related]
2. Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis.
Kovacheva M; Zepp M; Schraad M; Berger S; Berger MR
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590218
[TBL] [Abstract][Full Text] [Related]
3. Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.
Kovacheva M; Zepp M; Berger SM; Berger MR
Oncotarget; 2014 Jul; 5(14):5510-22. PubMed ID: 24980816
[TBL] [Abstract][Full Text] [Related]
4. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
5. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.
Reufsteck C; Lifshitz-Shovali R; Zepp M; Bäuerle T; Kübler D; Golomb G; Berger MR
Clin Exp Metastasis; 2012 Jun; 29(5):441-56. PubMed ID: 22407340
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
Bandyopadhyay A; Wang L; Chin SH; Sun LZ
Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
[TBL] [Abstract][Full Text] [Related]
7. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
Harms JF; Welch DR; Samant RS; Shevde LA; Miele ME; Babu GR; Goldberg SF; Gilman VR; Sosnowski DM; Campo DA; Gay CV; Budgeon LR; Mercer R; Jewell J; Mastro AM; Donahue HJ; Erin N; Debies MT; Meehan WJ; Jones AL; Mbalaviele G; Nickols A; Christensen ND; Melly R; Beck LN; Kent J; Rader RK; Kotyk JJ; Pagel MD; Westlin WF; Griggs DW
Clin Exp Metastasis; 2004; 21(2):119-28. PubMed ID: 15168729
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
9. Cilengitide inhibits metastatic bone colonization in a nude rat model.
Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T
Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
Bäuerle T; Peterschmitt J; Hilbig H; Kiessling F; Armbruster FP; Berger MR
Int J Oncol; 2006 Mar; 28(3):573-83. PubMed ID: 16465361
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
12. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
[No Abstract] [Full Text] [Related]
13. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
[TBL] [Abstract][Full Text] [Related]
14. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
Bäuerle T; Komljenovic D; Berger MR; Semmler W
J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.
Subik K; Shu L; Wu C; Liang Q; Hicks D; Boyce B; Schiffhauer L; Chen D; Chen C; Tang P; Xing L
Bone; 2012 Apr; 50(4):813-23. PubMed ID: 22266093
[TBL] [Abstract][Full Text] [Related]
17. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.
Hsu CH; Ma HP; Ong JR; Hsieh MS; Yadav VK; Yeh CT; Chao TY; Lee WH; Huang WC; Kuo KT; Fong IH; Lin CC; Su CM
Dis Markers; 2022; 2022():8446629. PubMed ID: 35903297
[TBL] [Abstract][Full Text] [Related]
19. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein.
Bäuerle T; Adwan H; Kiessling F; Hilbig H; Armbruster FP; Berger MR
Int J Cancer; 2005 Jun; 115(2):177-86. PubMed ID: 15688393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
